Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EPHX2 inhibitors(Epoxide hydratase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC17H21F4N3O3 |
InChIKeyKCYFENQWYLTXQO-UHFFFAOYSA-N |
CAS Registry1809885-25-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | US | 07 Feb 2021 |